Imbruvica is a cancer medication that treats chronic lymphocytic leukemia and mantle cell lymphoma. These are types of cancers that affect the white blood cells in body. Imbruvica belongs to a class of medications known as kinase inhibitors. Imbruvica works by suppressing the growth and spread of the cancer cells in the body.
Drug Name: Imbruvica
Generic name: Ibrutinib